Skip to Content

  • Search

View Additional Section Content

Indicate HF - A prospective, randomized, multicenter clinical trial. The purpose of this trial is to evaluate the potential benefit of a new heart failure (HF) diagnostic system for HF patients with cardiac resynchronzation therapy (CRT) devices. This new heart failure diagnostic system consists of three key components (1) new patient tools (2) new heart failure risk score (3) new heart failure clinician website.

Principal Investigator(s)
Robert A. Watson, III, M.D.

Clinical Trial Categories

  • Cardiology
Beth Bishop at 215-517-1027


  • Abington Medical Specialists

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details